Atlas Trials

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Clinical trial NCT05391867 · UNKNOWN

Trial details

NCT number
NCT05391867
Sponsor
Sir Salimullah Medical College Mitford Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2022-01-01
Primary completion
2022-12-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.